CPG
NMTR

Cornerstone Planning Group’s 9 Meters Biopharma NMTR Stock Holding History

Cornerstone Planning Group’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$52 Buy
+25
New +$57 ﹤0.01% 1548

Other funds holding NMTR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
ODFS
O'Donnell Financial Services San Rafael, California $290M AUM 15.6% 1-Year Est. Return

Cornerstone Planning Group's NMTR Position: Q4 2022 in Review

Cornerstone Planning Group opened a new position in 9 Meters Biopharma (NMTR) in Q4 2022: 25 shares worth $52. The stake represents ﹤0.01% of the portfolio and ranks #1548 among its holdings.

42 funds tracked by Wall St. Rank hold NMTR as of Q4 2022.

  • Cornerstone Planning Group held 25 shares of 9 Meters Biopharma worth $52 as of Q4 2022.
  • 9 Meters Biopharma was a new Cornerstone Planning Group position in Q4 2022.
  • 9 Meters Biopharma made up ﹤0.01% of Cornerstone Planning Group's portfolio in Q4 2022, its #1548 holding.
  • 42 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q4 2022.

Based on Cornerstone Planning Group's 13F filing for Q4 2022, filed 14 Feb 2023.